FATTY LIVER DISEASE
Clinical trials for FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old heart drug could be new hope for millions with fatty liver
Disease control Recruiting nowThis study is testing if digoxin, a medication used for heart conditions, can help treat a serious liver disease called NASH (now called MASH). Researchers will give 144 people with NASH either digoxin or a placebo pill daily for 24 weeks to see if it reduces liver inflammation a…
Matched conditions: FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First human test for new fatty liver pill begins
Disease control Recruiting nowThis is the first study in humans to test the safety and side effects of a new drug called NNC4005-0001 for fatty liver disease. About 60 adults with increased body weight and liver fat will receive either the new drug or a placebo (a dummy pill with no medicine) in a single dose…
Matched conditions: FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Massive hospital data dive seeks links between liver trouble and other illnesses
Knowledge-focused Recruiting nowThis study aims to understand how chronic liver diseases, like hepatitis and fatty liver, are connected to other health problems a person might have. Researchers will look back at the medical records of up to 15,000 patients from Tzu Chi hospitals to see how these conditions affe…
Matched conditions: FATTY LIVER DISEASE
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC